Searched for
ZYDUS LIFESCIENCES Q2
IDFC First Bank Q1 update: Loan book grows 21% YoY to Rs 3.05 lakh crore; shares rise 2%IDFC First Bank reported strong provisional Q1 FY27 business growth, with loans and advances rising 20.6% year-on-year and deposits increas...- Zydus Lifesciences ties up with Apollo Hospitals to offer Shield multi-cancer detection testZydus Lifesciences has partnered with Apollo Hospitals to introduce the Shield multi-cancer detection test in India, made possible through ...
- Explained: Why Tesla shares crashed 7% to record worst single-day fall in 1 year despite record Q2 salesTesla shares plunged over 7% despite the EV maker reporting record second-quarter deliveries that beat Wall Street estimates. Analysts attr...
- Market Skepticism: Why Tesla’s best delivery quarter still triggered a sell-offTesla delivered a stronger-than-expected 480,126 vehicles in Q2 2026, but shares slipped as investors looked beyond robust deliveries, focu...
- Tata Motors PV shares in focus as Iran-US conflict impacts JLR volumes in Q1. What's ahead?Tata Motors' luxury arm, Jaguar Land Rover, saw a significant 15.3% drop in retail sales for Q1 FY27. Disruptions from the Middle East conf...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities rallied as easing Middle East tensions pushed crude prices lower and dovish Fed remarks boosted sentiment. Sensex gained ne...
- Buy, Sell or Hold: Motilal Oswal recommends buy on CreditAccess Grameen; Nuvama maintains buy on APL ApolloBrokerages are optimistic about select Indian stocks despite sector-specific challenges. Nuvama maintains a 'Buy' on APL Apollo Tubes, expe...
- From deep correction to fresh peaks: 10 stocks soar from 52-week lows to new highs in just three monthsSeveral large-cap Indian companies have seen their stock prices surge from 52-week lows to highs within just three months. This impressive ...
- Macros, AI, geopolitical overhang to drag Q1 showing of IT cos: Motilal OswalIndian IT firms are bracing for a subdued first quarter of FY27, with global economic headwinds, AI's impact, and geopolitical tensions dam...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 3...
- Market Trading Guide: Finolex Cables among 2 stock recommendations for TuesdayDomestic equities closed higher on positive Asian cues, falling crude oil prices and hopes of an India-US trade deal. Analysts recommend bu...
- Residential sales dip to lowest since Jan 2023 amid West Asia war, impacting buyer sentimentResidential sales in India experienced a significant dip in April-June, reaching the lowest point since early 2023. Geopolitical tensions a...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Zydus, Sunshine to set up $20 million pharma JV in Sri LankaIndian pharmaceutical giant Zydus Lifesciences has partnered with Sri Lanka's Sunshine Healthcare Lanka to establish a new manufacturing fa...
- Federal Bank among 6 stocks that hit 52-week highs, rally up to 15% in a monthSix BSE200 stocks, including Federal Bank and Bharat Forge, hit fresh 52-week highs amid a strong market rally, reflecting bullish momentum...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Zydus Lifesciences shares fall 2% as firm acquires US-based Assertio Holdings for $166 millionZydus Lifesciences' shares dipped 2% after completing the $166.4 million acquisition of US-based Assertio Holdings Inc. The deal, finalized...
- Stocks in news: Prime Focus, Groww, GIC RE, Wipro, NykaaIndian benchmark indices traded with a positive bias, with the Nifty consolidating near the 24,000 mark and closing near its day's high. Se...
- Zydus Lifesciences completes acquisition of AssertioThe company has successfully completed the cash tender offer, through wholly-owned subsidiary, Zara Merger Sub Inc, for all the outstanding...
- Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?Investors have a final opportunity to tender shares in buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems and ...
Load More
